C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2004
12/29/2004	EP1299391B1 Indolinospiropyran compounds and methods for their manufacture
12/29/2004	EP1263723A4 Ningalin b analogs employable for reversing multidrug resistance
12/29/2004	EP1176140B1 Amide compounds and medicinal use thereof
12/29/2004	EP0941092B1 Use of nk-1 receptor antagonists for treating major depressive disorders
12/29/2004	CN1558899A Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
12/29/2004	CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/29/2004	CN1557814A Homocamptoth-ecine compounds, their preparation process and use
12/29/2004	CN1182123C Substituted bicyclic derivatives useful as anticancer agents
12/28/2004	US6835845 Methine compound, material for organic luminescence element, and organic luminescence element using the same
12/28/2004	US6835737 Quinoline inhibitors of cGMP phosphodiesterase
12/28/2004	US6835735 Anticancer, tyrosine kinase inhibitors
12/28/2004	US6835731 Chemokine receptor binding heterocyclic compounds
12/28/2004	US6835725 Cyanine dye containing heterocylic rings; satisfies light stability, favorable signal/noise rato, damage free application to the substrate material, use in the information layer in a write-once optical data carrier
12/28/2004	US6835474 Red fluorescent dyes having high fluorescent strength and high color purity; high luminance; high efficacy by low voltage-driving; stability; durability; color conversion filter, pulp dyeing; photographic dye; sensitizers
12/28/2004	CA2105923C 7-isoindolinyl-quinolone derivatives and 7-isoindolinyl-naphthyridone derivatives
12/25/2004	CA2472294A1 New derivatives of benzo[a]pyrano[3,2-h]acridin-7-one, a process for their preparation and pharmaceutical compounds containing them
12/23/2004	WO2004111056A2 Compound libraries of spiro-benzodioxine-piperidines
12/23/2004	WO2004111042A1 N-heterocyclyl phenyl-substituted cyclic ketoenols
12/23/2004	WO2004111014A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
12/23/2004	WO2004110449A1 Aporphine and oxoaporphine and the medical use thereof
12/23/2004	WO2004110385A2 Modulators of the glucocorticoid receptor and method
12/23/2004	WO2003101995A8 Camptothecins with a modified lactone ring
12/23/2004	US20040259909 using an agonist of alpha 7 nicotinic acetylcholine receptors rather than those of 5HT3 receptors; tropisetron; spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidine-2'-one; N-(1-azabicyclo[2.2.2]oct-3-yl)(3-phenylbenzamide); N-(nitrogen heterocycle)-carboxamides or thiocarboxamides
12/23/2004	US20040259907 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents
12/23/2004	US20040259901 Mixed kappa/mu opioids and uses thereof
12/23/2004	US20040259896 N-hydroxy-5-methyl-6-{[4-(3-methylphenyl)piperazin-1-yl]carbonyl}-5-azaspiro[2.5]octane-7-carboxamide for example; treating arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions
12/23/2004	US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example
12/23/2004	US20040259888 Antiischemic agents; cardiovascular disorders; analgesics; neurodegenerative disease
12/23/2004	US20040259856 Fermentation product of marine actinomyces strains; antiproliferative agents; anticancer agents
12/23/2004	CA2531406A1 Aporphine and oxoaporphine and the medical use thereof
12/23/2004	CA2528888A1 N-heterocyclylphenyl-substituted cyclic ketoenols
12/22/2004	EP1489418A1 Novel fluorescent label compounds
12/22/2004	EP1489082A1 Intermediate compounds
12/22/2004	EP1487840A1 Crystalline polymorphic form of irinotecan hydrochloride
12/22/2004	EP1487839A1 Methods for producing norgalanthamine, as well as isomers, salts and hydrates thereof
12/22/2004	EP1487822A2 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors
12/22/2004	EP1487813A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
12/22/2004	EP1487806A1 4-anilino quinazoline derivatives as antiproliferative agents
12/22/2004	EP1487795A2 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
12/22/2004	CN1556811A 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/22/2004	CN1556105A Synthesis method of N-benzyl-4-piperidyl formaldehgde
12/22/2004	CN1181075C Pyrimidine-4-keto compound, its preparation method and medicine composition containing them
12/21/2004	US6833386 Diaminofluorescein derivatives
12/16/2004	WO2004108133A2 Modulators of vr1 receptor
12/16/2004	WO2004096805A9 Lyotropic liquid crystal systems based on sulfonated perylenetetracarboxylic acid dibenzimidazoles
12/16/2004	WO2004078030B1 Rhodol derivatives useful as image dyes
12/16/2004	US20040254376 Cyclic amidine derivative
12/16/2004	US20040254199 For plants, animals; nematocides
12/16/2004	US20040254167 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/16/2004	US20040254163 New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
12/16/2004	US20040254159 Antiproliferative agents
12/16/2004	US20040254146 Carboxylate salts of galantamine and their pharmaceutical use
12/16/2004	CA2524376A1 Substituted imidazolopyrazine and triazolopyrazyne derivatives: gabaa receptor ligands
12/15/2004	EP1486549A1 Organic electroluminescent element
12/15/2004	EP1485390A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
12/15/2004	EP1485387A1 Carbamates as hiv protease inhibitors
12/15/2004	EP1485372A2 Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides
12/15/2004	EP1485369A1 Blue 3h-naphtho- 2,1-b]-pyran derivatives and use thereof
12/15/2004	EP1278742B1 Chromenylmethylpyrimidinediamines as antibacterial agents
12/15/2004	CN1555379A Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/15/2004	CN1555378A Process for preparation of amidine derivatives
12/15/2004	CN1555377A 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
12/15/2004	CN1555376A 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
12/15/2004	CN1555375A Compounds for inhibiting the release of inflammatory cytokines
12/15/2004	CN1554658A New process for fully synthesizing galanthamine
12/15/2004	CN1554649A Metabotropic glutamate receptor antagonists for treating central nervous system diseases
12/14/2004	US6831180 Substituted tertiary carboxylic oxacycloalkane acids, used to prepare anhydro-homo-harringtonic acids by semi-synthesis; hydroxyl function of a cephalotaxane is esterified with a 2-carboxyl-2-alkyl-1-oxacycloalkane claimed intermediate; (indexing from 7169774 added)
12/14/2004	US6831090 Having microtubule-stabilizing effects and cytotoxic activity against rapidly proliferating cells, such as, tunior cells or other hyperproliferative cellular disease
12/14/2004	US6831083 Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof
12/14/2004	US6831080 Cinnamide derivatives as KCNQ potassium channel modulators
12/14/2004	US6831075 Heterocyclic substituted pyrazolones
12/09/2004	WO2004106493A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
12/09/2004	WO2004106346A1 Indole derivatives with an improved antipsychotic activity
12/09/2004	WO2004106333A1 Azabicycloalkane compounds as muscarinic receptor antagonists
12/09/2004	WO2004106328A1 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/09/2004	WO2004106310A1 Novel 3-substituted-1,4-benzodiazepines
12/09/2004	WO2004106298A1 Indole derivatives with an improved antipsychotic activity
12/09/2004	WO2004106293A2 Oxazolyl - and thiazolyl - purine based tricyclic compounds.
12/09/2004	WO2004105700A2 Compounds, methods and pharmaceutical compositions for inhibiting parp
12/09/2004	WO2004092203A3 Process for preparing macrocyclic compounds
12/09/2004	US20040249167 Substituted benzopyrans as selective estrogen receptor-beta agonists
12/09/2004	US20040249162 From a pyrrolidinone compound; coloring high molecular weight material
12/09/2004	US20040248925 Use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence
12/09/2004	US20040248923 Novel 4-anilinoquinoline-3-carboxamides
12/09/2004	US20040248899 Fused bicyclic-substituted amines as histamine-3 receptor ligands
12/09/2004	US20040248889 Analgesics; synthesis
12/09/2004	US20040248820 Administering 2-phthalimidoglutaric acid; vision defects; antitumor agents; anticancer agents
12/09/2004	CA2527583A1 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/09/2004	CA2527420A1 Compounds, methods and pharmaceutical compositions for inhibiting parp
12/09/2004	CA2527195A1 Novel 3-substituted-1,4-benzodiazepines
12/09/2004	CA2525282A1 Indole derivatives with an improved antipsychotic activity
12/08/2004	EP1483266A1 Spiro compounds with npy antagonistic activity
12/08/2004	EP1483263A1 Thiazolyl urea compounds for the treatment of cancer
12/08/2004	EP1483254A1 Resistance-repellent retroviral protease inhibitors
12/08/2004	EP1483251A1 C3-cyano epothilone derivatives
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP0831094B1 Fused polycyclic heterocycle derivatives
12/08/2004	CN1553913A Process for the direct preparation of pyrrolo [3,4-c]pyrroles
12/08/2004	CN1553912A Process for the preparation of diketopyrrolopyrroles
12/08/2004	CN1553911A Pyrrole derivatives, their preparation and their therapeutic uses

1 ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 ... 298